DIBBS #SPE2DP-26-T-2575

DLA Procurement of Gabapentin Capsules, 100 mg, for USS Makin Island

This procurement opportunity from the Defense Logistics Agency (DLA) seeks Gabapentin Capsules for military medical supply: - Government Buyer: - Defense Logistics Agency (DLA) - Sub-agency: DLA Troop Support Medical Supply Chain Pharmacy FSA, Philadelphia, PA - Buyer: James McCullough (Buyer Code DJM0448) - OEMs (Original Equipment Manufacturers): - Marlex Pharmaceuticals Inc (NDC10135-0644-01) - Cipla USA Inc (NDC69097-0813-07) - Sciegen Pharmaceuticals Inc (NDC50228-0179-01) - Vendors: - Marlex Pharmaceuticals Inc - Cipla USA Inc - Sciegen Pharmaceuticals Inc - Products Requested: - Gabapentin Capsules, 100 mg, 100-count bottles - NSN: 6505-01-387-1892 - Quantity: 5 bottles (each bottle contains 100 capsules) - Approved NDCs: 10135-0644-01, 69097-0813-07, 50228-0179-01 - Unique or Notable Requirements: - Strict packaging, labeling, and medical marking standards per DLA requirements - Domestic sourcing restrictions apply - Delivery required within 5 days of award (FOB destination) - Delivery location: USS Makin Island LHD 8 (FPO AP 96672) - Controlled room temperature storage required - Place of Performance/Delivery: - Delivery to USS Makin Island LHD 8 (FPO AP 96672) - Contracting office at DLA Troop Support Medical Supply Chain Pharmacy FSA, 700 Robbins Avenue, Philadelphia, PA

Description

GABAPENTIN CAPSULES (QTY: 5, NSN: 6505-01-387-1892, Purchase Request: 7016153280) Approved Sources: - CAGE: 1TAP7, Part No: NDC10135-0644-01, Company: MARLEX PHARMACEUTICALS INC - CAGE: 7WV84, Part No: NDC69097-0813-07, Company: CIPLA USA INC - CAGE: 8NLP1, Part No: NDC50228-0179-01, Company: SCIEGEN PHARMACEUTICALS INC

View original listing